We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,354

Reminder: Pharma Manufacturers Now Required to Report Average Sales Price (ASP) Data for Part B Drugs Via New System
  • Arent Fox LLP
  • USA
  • April 23 2018

As discussed in a prior blog post, pharmaceutical manufacturers whose drugs are reimbursed under Medicare Part B must now report certain product and


Why the Healthcare Industry Should Pay Particular Attention to Drug and Alcohol Issues in the Workplace
  • Jackson Lewis PC
  • USA
  • March 21 2018

While all employers struggle with navigating the ever-changing landscape of drug and alcohol issues in the workplace, healthcare employers should pay


Big Brother is a Pill: Digital Tracking Drugs
  • McGuireWoods LLP
  • USA
  • January 11 2018

Drug adherence programs have significantly evolved over the last few years with drug companies, health plans, and providers taking steps to monitor


SAMHSA Further Revises the Part 2 Drug and Alcohol Abuse Confidentiality Requirements
  • Bass, Berry & Sims PLC
  • USA
  • January 11 2018

On January 3, 2018, the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) issued a


SEC Scrutinizes Pumping of Blockchain-Related Securities
  • Reed Smith LLP
  • USA
  • January 9 2018

The U.S. Securities and Exchange Commission ("SEC") is continuing to increase its scrutiny of companies that might be taking advantage of investor


Truck Drivers’ Drug Arrests Often Overlooked
  • Stark & Stark
  • USA
  • November 27 2017

Trucking companies are not always notified when a driver is arrested for drugs. For example, recently, a truck driver was arrested after police found


Clinical trials in the USA
  • Perkins Coie LLP
  • USA, Global
  • October 11 2017

A structured guide to clinical trials in the USA


Giving Telemedicine More Room to Breathe: Recent and Pending State and Federal Actions in the World of Online Prescribing
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • July 10 2017

On October 18, 2008, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 (the “Haight Act”) came into law as the federal government’s


OIG Issues Top 25 Unimplemented Cost-Savings and Quality-Improvement Recommendations for HHS Programs
  • Reed Smith LLP
  • USA
  • June 2 2017

The Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) has released the 2017 edition of its Compendium of


Chinese Food and Drug Administration (CFDA) Proposes New Patent Linkage and Data Protection Regime
  • Spruson & Ferguson
  • China
  • May 18 2017

On 12 May, 2017 the CFDA published its intention to work on a new patent linkage and data protection system for China as part of a reform of its